Joseph Driscoll - Dec 22, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Chief Financial Officer
Signature
/s/ Joseph Driscoll, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Dec 22, 2022
Transactions value $
$110,000
Form type
4
Date filed
12/27/2022, 03:05 PM
Previous filing
Dec 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Options Exercise $110K +250K +2000% $0.44* 263K Dec 22, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKYA Employee Stock Option (Right to Buy) Options Exercise $0 -250K -69.26% $0.00 111K Dec 22, 2022 Common Stock 250K $0.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will be fully vested on 03/18/2023.